Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD (Non-alcoholic Fatty Liver Disease)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06932289
What this trial is testing

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
VA Greater Los Angeles Healthcare System 54
Not applicableStudy completedNCT01050140
What this trial is testing

The Metabolic Effects of a High Fructose Versus a High Glucose Diet in Overweight Men

Who this might be right for
Hepatic Fatty Acid MetabolismSystemic Insulin ResistanceOxidative Stress+1 more
University of Nottingham 32
Not applicableUnknownNCT02764047
What this trial is testing

Probiotics in the Treatment of NAFLD

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisFatty Liver, Nonalcoholic+1 more
Federal University of Health Science of Porto Alegre 58
Testing effectiveness (Phase 2)Looking for participantsNCT07238985
What this trial is testing

Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
Tanta University 50
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Early research (Phase 1)Study completedNCT05294458
What this trial is testing

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Who this might be right for
Non-alcoholic SteatohepatitisType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
AstraZeneca 10
Testing effectiveness (Phase 2)Study completedNCT06054815
What this trial is testing

Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

Who this might be right for
NON-ALCOHOLIC STEATOHEPATITIS
NeuroBo Pharmaceuticals Inc. 109
Testing effectiveness (Phase 2)Study completedNCT01694849
What this trial is testing

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Genfit 275
Not applicableStudy completedNCT04581421
What this trial is testing

The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content

Who this might be right for
NAFLDOverweight and ObesityMetabolic Syndrome+1 more
Hvidovre University Hospital 12
Not applicableUnknownNCT05076058
What this trial is testing

Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver

Who this might be right for
Fatty Liver Disease
Sun Yat-sen University 118
Testing effectiveness (Phase 2)Study completedNCT00323414
What this trial is testing

Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 37
Not applicableNot Yet RecruitingNCT07336563
What this trial is testing

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more
Jarosław Drobnik 10,000
Not applicableStudy completedNCT03986684
What this trial is testing

Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverMetabolic Syndrome
Hippocration General Hospital 32
Not applicableLooking for participantsNCT07265544
What this trial is testing

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Who this might be right for
Liver NeoplasmHBV InfectionNon-alcoholic Fatty Liver Disease NAFLD+1 more
Nanfang Hospital, Southern Medical University 240
Not applicableStudy completedNCT01061684
What this trial is testing

NAFLD Pediatric Database 2

Who this might be right for
Liver Disease
Johns Hopkins Bloomberg School of Public Health 969
Early research (Phase 1)Study completedNCT05441904
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Poxel SA 16
Not applicableUnknownNCT06111859
What this trial is testing

Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification

Who this might be right for
Liver Disease ChronicFibrosis, LiverLiver Steatoses+4 more
King's College Hospital NHS Trust 180
Not applicableStudy completedNCT06195943
What this trial is testing

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNASHExercise+1 more
Milton S. Hershey Medical Center 17
Not applicableUnknownNCT05696808
What this trial is testing

Effect of Indian Hepatoprotective Diet in Reversibility of NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMetabolic Syndrome
Institute of Liver and Biliary Sciences, India 60
Not applicableStudy completedNCT03945123
What this trial is testing

Effects of Red Ginseng on Liver Function

Who this might be right for
Liver Dysfunction
Chuncheon Sacred Heart Hospital 94
Next Page